Emergent BioSolutions News

Back after the DOT-COM bomb in 2000 people were looking for the next thing.A Many in the Metro Washington area were sure it would be bio technology but that quickly seemed to go nowhere.A Or did it?A Well, not really.A Lots of money, research, investment, and brain power did indeed go into biotech and executives like Fuad El-Hibri have created ...

Emergent Biosolutions has seen some disappointments over the last few months. The company is the only provider of an FDA approved Anthrax vaccine and EBS primarily sells its products to the United States Strategic National Stockpile .

Emergent BioSolutions Inc. announced today that it has been advised by the Office of the Biomedical Advanced Research and Development Authority that the Request for Proposal for the procurement of rPA vaccines has been cancelled in favor of a Broad Agency Announcement for rPA vaccine development.

Emergent BioSolutions Inc. is pleased to announce the appointment of Steven Chatfield, Ph.D. as Senior Vice President, Biodefense effective immediately.

In a potential sign of a better economy, companies have announced expansions recently and plan to hire more workers.

Maryland's governor says a biopharmaceutical company is building a bio-processing center in east Baltimore.

Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million.

Emergent BioSolutions Inc. November 5, 2009 5:00 pm ET Executives Robert Burrows a ' VP, IR Fuad El-Hibri a ' CEO and Chairman Don Elsey a ' CFO and SVP, Finance & Administration Denise Esposito a ' SVP, Legal Affairs, General Counsel and Secretary Jim Jackson a ' SVP and Chief Scientific Officer Dan Abdun-Nabi a ' President and COO Analysts Eric ...

MURFREESBORO, Tenn.-- --National HealthCare Corporation , a publicly traded long-term health care company, today announced net income before taxes in... LOSA ANGELES-- --USC Marshall School of Business faculty experts are available to comment on current economic news, including extension of unemployment benefits and homebuyer tax credits...

Compellent Technologies Inc. will replace Central Pacific Financial Corp. , and Emergent BioSolutions Inc.

Emergent BioSolutions may hire 25 to 50 people for a proposed plant. A Rockville biotech company is finalizing a deal to purchase a manufacturing facility near Johns Hopkins Bayview Medical Center and could invest between $15 million and $20 million in the property.

A handful of local companies are among the 200 best small public companies in the U.S., according to Forbes' annual list.

ST. PAUL, Minn.-- --Ecolab will host a live webcast of its third quarter investor conference call.

Emergent BioSolutions Inc. announced today it will report financial results for third quarter 2009 on Thursday, November 5, 2009, after market close.

Emergent BioSolutions wins $4.9 m[illion] anthrax vaccine [dmPA7909] grant "Emergent BioSolutions Inc.

Main Category: Bio-terrorism / Terrorism Also Included In: Immune System / Vaccines Article Date: 02 Oct 2009 Emergent BioSolutions Inc.

BeaconEquity.com announces an investment report featuring biopharmaceutical company XOMA Ltd.

Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases , part of the National Institutes of Health, to further the development of one of Emergenta s advanced anthrax vaccine candidates known as dmPA7909.

On September 15, 2009, Drake will drop So Far Gone, his... PARSIPPANY, N.J.-- --B&G Foods, Inc.

The company promised to expand and hire new employees if given the money. If a consumer defaults on a loan, some type of penalty would be imposed.